- Home
- PLCE vs CRDF Comparison
PLCE vs CRDF Comparison
Compare PLCE & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLCE
- CRDF
- Stock Information
- Founded
- PLCE 1969
- CRDF 1999
- Country
- PLCE United States
- CRDF United States
- Employees
- PLCE N/A
- CRDF N/A
- Industry
- PLCE Clothing/Shoe/Accessory Stores
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PLCE Consumer Discretionary
- CRDF Health Care
- Exchange
- PLCE Nasdaq
- CRDF Nasdaq
- Market Cap
- PLCE 169.6M
- CRDF 144.4M
- IPO Year
- PLCE 1997
- CRDF N/A
- Fundamental
- Price
- PLCE N/A
- CRDF $2.23
- Analyst Decision
- PLCE Hold
- CRDF Strong Buy
- Analyst Count
- PLCE 1
- CRDF 5
- Target Price
- PLCE $7.00
- CRDF $11.10
- AVG Volume (30 Days)
- PLCE 715.3K
- CRDF 765.0K
- Earning Date
- PLCE 09-05-2025
- CRDF 11-06-2025
- Dividend Yield
- PLCE N/A
- CRDF N/A
- EPS Growth
- PLCE N/A
- CRDF N/A
- EPS
- PLCE N/A
- CRDF N/A
- Revenue
- PLCE $1,338,867,000.00
- CRDF $545,000.00
- Revenue This Year
- PLCE N/A
- CRDF N/A
- Revenue Next Year
- PLCE $0.68
- CRDF N/A
- P/E Ratio
- PLCE N/A
- CRDF N/A
- Revenue Growth
- PLCE N/A
- CRDF N/A
- 52 Week Low
- PLCE $3.66
- CRDF $1.90
- 52 Week High
- PLCE $17.19
- CRDF $5.64
- Technical
- Relative Strength Index (RSI)
- PLCE 63.80
- CRDF 52.32
- Support Level
- PLCE $6.18
- CRDF $1.99
- Resistance Level
- PLCE $7.36
- CRDF $2.27
- Average True Range (ATR)
- PLCE 0.61
- CRDF 0.10
- MACD
- PLCE 0.01
- CRDF 0.05
- Stochastic Oscillator
- PLCE 65.13
- CRDF 91.67
About PLCE Children's Place Inc. (The)
Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It designs, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names. The Company classifies its business into two segments: The Children's Place U.S. and The Children's Place International.
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.